Key result
Standardized baseline imaging and decision rules remain unvalidated, leaving recurrent VTE diagnosis challenging.
Why the study?
The diagnostic management of recurrent VTE is challenging because clinical decision rules are not validated and imaging interpretation is difficult due to residual abnormalities from prior events.
This review highlights the challenges in diagnosing recurrent VTE and suggests a standardized baseline examination after anticoagulation cessation to aid future imaging interpretation.
Answers are grounded in this paper and cite their sources.
Urges caution applying unvalidated rules for recurrent VTE; leaves open whether standardized baseline exams improve diagnostic accuracy.
The diagnostic management of recurrent venous thromboembolism (VTE) is a clinical dilemma. Clinical decision rules are well validated in patients with a first episode of clinically suspected VTE but are not validated in patients with a suspected recurrent event. D-dimer testing could safely exclude a recurrent VTE but is subject to several limitations. Imaging could objectively exclude or establish the diagnosis of recurrent VTE, but due to persistent residual abnormalities after the first or previous event, imaging interpretation can be difficult. To limit the presence of uncertain imaging test results, a standardized baseline examination after anticoagulation cessation should be considered. This review will elaborate on these issues and will discuss the recent advancements in this area.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2012) conducted a review in Recurrent venous thromboembolism (VTE). Diagnostic management (clinical decision rules, D-dimer testing, imaging) was evaluated. Diagnostic management of recurrent VTE remains challenging due to unvalidated clinical decision rules and imaging limitations, suggesting a need for standardized baseline examinations.
Synapse has enriched 10 related papers. Consider them for comparative context: